Fritsch, K., Schorb, E., Hader, C., Fricker, H., Ihorst, G., Finke, J. und Illerhaus, G. (2020) High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) [cd]. Freiburg: Universität. doi:10.1038/leu.2016.334.
Chicago Manual of Style 17th edition (full note)Fritsch, Kristina, Elisabeth Schorb, Claudia Hader, Heidi Fricker, Gabriele Ihorst, Jürgen Finke, und Gerald Illerhaus. High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Cd. Freiburg: Universität, [2020?], Freiburg: Universität, [2020?]. https://doi.org/10.1038/leu.2016.334.
American Psychological Association 7th editionFritsch, K., Schorb, E., Hader, C., Fricker, H., Ihorst, G., Finke, J., & Illerhaus, G. (ca. 2020). High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) [Cd]. Universität. https://doi.org/10.1038/leu.2016.334
Modern Language Association 9th editionFritsch, K., E. Schorb, C. Hader, H. Fricker, G. Ihorst, J. Finke, und G. Illerhaus. High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). cd, Universität, 2020, https://doi.org/10.1038/leu.2016.334.
ISO-690 (author-date, Deutsch)FRITSCH, Kristina, Elisabeth SCHORB, Claudia HADER, Heidi FRICKER, Gabriele IHORST, Jürgen FINKE und Gerald ILLERHAUS, 2020. High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). Freiburg: Universität